Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Initiation of phase I/II study of CG-7870 plus radiation in early-stage prostate cancer

April 24, 2003

Diatos licenses European rights for Super-Leu-Dox

April 24, 2003

Novel modulators of LPA receptors and their use in cancer, wound healing, etc.

April 24, 2003

Aventis scientists identify novel protein kinase inhibitors

April 24, 2003

Novel tyrosine kinase inhibitors under study at Merck & Co.

April 24, 2003

Three series of antitumor agents prepared and tested at Synta

April 24, 2003

AGI Dermatics regains rights to Dimericine

April 23, 2003

Phase II studies of ILX-651 planned

April 23, 2003

Northwest Biotherapeutics receives NCI grant for tumor growth inhibition

April 23, 2003

Vitamin E analogue sensitizes Jurkat cells by suppressing NF-kB activation

April 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026